Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

DYDX community votes to allocate 75% of protocol fees to token buybacks, up from 25%, aiming to boost price and market confidence.

The $1 million crypto portfolio marks the Czech National Bank’s first direct purchase of digital assets, including bitcoin, a ...

Vitalik Buterin and the Ethereum Foundation have introduced the Trustless Manifesto to reinforce the core values of ...

Waymo is offering autonomous rides on local freeways to some customers, marking a big step in efforts to integrate driverless ...

The freeway expansion comes as the autonomous ride-sharing market sees increasing competition. Waymo currently leads the ...

The study presents important insights into the regulation of muscle hypertrophy, regulated by Muscle Ankyrin Repeat Proteins (MARPs) and mTOR. The methods are overall solid and complementary, with ...

Notre Dame basketball needed to close out this brief three-game homestand the right way with what's coming next. Did the ...

The Fusaka upgrade will bring better scalability, lower gas costs, improved validator performance, smoother transactions and ...

Quiet Lab Mouthpiece officially launches in the USA, UK, Canada & Australia — a breakthrough quietlab anti-snoring and ...

As major networks like Solana, BNB, and XRP continue reinforcing global adoption through speed, liquidity, and financial ...

FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...